• Advocating for expanded and equal access of telehealth use in healthcare -- Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act. Medicare Coverage of Innovative Technology (MCIT) - H.R. 1691, the Ensuring Patient Access to Critical Breakthrough Products Act. EtO Emissions Standards. PFAS regulation. Artificial intelligence regulation in healthcare, and the broader government.
• Advocating for expanded and equal access of telehealth use in healthcare Medicare Coverage of Innovative Technology (MCIT) - H.R. 1691, the Ensuring Patient Access to Critical Breakthrough Products Act.
• S. 866: The American Innovation and Jobs Act H.R. 2673: The American Innovation and R&D Competitiveness Act of 2023

Duration: November 5, 2020 to present

General Issues: Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Medical/Disease Research/Clinical Labs, Science/Technology

Spending: about $380,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2020: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)